Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v12-FR
Language French French
Date Updated 2020-07-31 2020-07-31
Drug Identification Number 02473305 02473305
Brand name AURO-QUINAPRIL HCTZ AURO-QUINAPRIL HCTZ
Common or Proper name Hydrochlorothiazide; Quinapril (Quinapril Hydrochloride) Hydrochlorothiazide; Quinapril (Quinapril Hydrochloride)
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients HYDROCHLOROTHIAZIDE QUINAPRIL HYDROCHLOROTHIAZIDE QUINAPRIL
Strength(s) 12.5MG 20MG 12.5MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28 & 90 28 & 90
ATC code C09BA C09BA
ATC description ACE INHIBITORS, COMBINATIONS ACE INHIBITORS, COMBINATIONS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-10-09 2019-10-09
Estimated end date
Actual end date 2020-07-30 2020-07-30
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments